Date:27-Apr-2024  Time: 6:01 PM
 
 
        
Balaxi Pharmaceuticals Ltd
Quarters:       (Rs. In Crores)
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
Type3Qtr2Qtr1Qtr4Qtr
Net Sales12.7016.5525.0430.35
Other Income1.031.150.130.18
Total Income13.7317.7025.1730.53
Total Expenditure 12.4215.6421.2724.95
Operating Profit1.312.073.905.58
Interest0.410.360.260.23
Gross Profit0.901.703.645.36
Depreciation0.130.130.130.27
Tax0.310.390.960.08
Deferred Tax-0.030.000.001.07
Reported Profit After Tax0.491.182.553.94
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com